Diagnostic yield of pleural fluid adenosine deaminase, GeneXpert MTB/RIF and Ziehl–Neelsen staining and their agreement with a composite clinical diagnosis of tuberculous pleural effusion: a hospital-based cross-sectional study from the Bundelkhand r

Background: Tuberculous pleural effusion (TPE) is common in India, but its paucibacillary nature hampers microbiological confirmation. Objectives: To describe the diagnostic yield of pleural fluid adenosine deaminase (ADA), GeneXpert MTB/RIF and Ziehl–Neelsen (ZN) staining, alone and combined, in exudative pleural effusion, and their agreement with a composite diagnosis of TPE. Methods: This cross-sectional study enrolled 138 adults with exudative pleural effusion at a tertiary centre in Jhansi, Uttar Pradesh. Pleural fluid underwent ADA (cut-off >40 IU/L), ZN staining and GeneXpert. TPE was defined by a composite standard (microbiological confirmation and/or ADA >40 IU/L with lymphocytic predominance and compatible clinico-radiological features). Because the index tests formed part of this standard, sensitivity and specificity are reported as agreement indices, not independent accuracy. Results: Of 138 patients, 93 (67.4%) had TPE (48 microbiologically confirmed). ADA was >40 IU/L in 67.4%, GeneXpert positive in 30.4% (rifampicin resistance 1.4%) and ZN positive in 8.7%. ADA showed sensitivity 80.6% and specificity 60.0%; all 18 false positives were neutrophil-predominant effusions. GeneXpert and ZN sensitivities were 45.2% and 12.9% (specificity 100% by definition). Among microbiologically confirmed cases, ADA was >40 IU/L in only 62.5%. Combining the three tests identified all 93 cases (accuracy 87.0%), each contributing cases missed by the others. Conclusion: ADA is a rapid initial test, but raised values in neutrophil-predominant effusions warrant caution and a normal ADA does not exclude TPE. GeneXpert adds microbiological confirmation and resistance detection; ZN has little stand-alone value. Combined testing increases yield. Validation against culture and treatment response is needed.

Authors

Publication Details

Journal
International Journal of Medical Sciences and Academic Research
Published
2026-11-12
DOI
https://doi.org/10.5281/zenodo.23984966
Primary Topic
Pleural and Pulmonary Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Diagnostic yield of pleural fluid adenosine deaminase, GeneXpert MTB/RIF and Ziehl–Neelsen staining and their agreement with a composite clinical diagnosis of tuberculous pleural effusion: a hospital-based cross-sectional study from the Bundelkhand r

Gulshan Kumar, Rajiv Kumar, Namita Srivastava, Madhurmay
International Journal of Medical Sciences and Academic Research
Pleural and Pulmonary Diseases
article

Diagnostic yield of pleural fluid adenosine deaminase, GeneXpert MTB/RIF and Ziehl–Neelsen staining and their agreement with a composite clinical diagnosis of tuberculous pleural effusion: a hospital-based cross-sectional study from the Bundelkhand r

Gulshan Kumar, Rajiv Kumar, Namita Srivastava, Madhurmay
article en

Abstract

Background: Tuberculous pleural effusion (TPE) is common in India, but its paucibacillary nature hampers microbiological confirmation. Objectives: To describe the diagnostic yield of pleural fluid adenosine deaminase (ADA), GeneXpert MTB/RIF and Ziehl–Neelsen (ZN) staining, alone and combined, in exudative pleural effusion, and their agreement with a composite diagnosis of TPE. Methods: This cross-sectional study enrolled 138 adults with exudative pleural effusion at a tertiary centre in Jhansi, Uttar Pradesh. Pleural fluid underwent ADA (cut-off >40 IU/L), ZN staining and GeneXpert. TPE was defined by a composite standard (microbiological confirmation and/or ADA >40 IU/L with lymphocytic predominance and compatible clinico-radiological features). Because the index tests formed part of this standard, sensitivity and specificity are reported as agreement indices, not independent accuracy. Results: Of 138 patients, 93 (67.4%) had TPE (48 microbiologically confirmed). ADA was >40 IU/L in 67.4%, GeneXpert positive in 30.4% (rifampicin resistance 1.4%) and ZN positive in 8.7%. ADA showed sensitivity 80.6% and specificity 60.0%; all 18 false positives were neutrophil-predominant effusions. GeneXpert and ZN sensitivities were 45.2% and 12.9% (specificity 100% by definition). Among microbiologically confirmed cases, ADA was >40 IU/L in only 62.5%. Combining the three tests identified all 93 cases (accuracy 87.0%), each contributing cases missed by the others. Conclusion: ADA is a rapid initial test, but raised values in neutrophil-predominant effusions warrant caution and a normal ADA does not exclude TPE. GeneXpert adds microbiological confirmation and resistance detection; ZN has little stand-alone value. Combined testing increases yield. Validation against culture and treatment response is needed.

International Journal of Medical Sciences and Academic Research
Good health and well-being
Pleural and Pulmonary Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon